ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,459.10
1.11%
US Tech 100
18,514.00
1.00%
Dow Jones
40,589.34
1.64%
Brent Oil
79.745
0.00%
Bitcoin
67,895.25
-0.03%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX

  6. Serina Therapeutics Inc (SER) Quote

Serina Therapeutics Inc

Serina Therapeutics Inc (SER)

Strategic Energy Resources Limited
10.56
0.56
(5.60%)
Closed July 27 4:00PM
Delayed by 15 minutes
10.70
0.14
(1.33%)
After Hours: 7:59PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
10.56
Bid
-
Ask
-
Volume
12,255
9.77 Day's Range 10.8999
5.9262 52 Week Range 19.93
Market Cap
88.851M
Previous Close
10.00
Open
10.23
Last Trade
100
@
10.56
Last Trade Time
Financial Volume
$ 128,792
VWAP
10.5094
Average Volume (3m)
20,683
Shares Outstanding
8,413,889
Dividend Yield
-
PE Ratio
-6.00
Earnings Per Share (EPS)
-1.76
Revenue
142k
Net Profit
-14.8M

About Serina Therapeutics Inc

AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging... AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
serinatherapeutics.com
Headquarters
Dover, Delaware, USA
Founded
1970
Serina Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the American Stock Exchange with ticker SER. The last closing price for Serina Therapeutics was $10. Over the last year, Serina Therapeutics shares have traded in a share price range of $ 5.9262 to $ 19.93.

Serina Therapeutics currently has 8,413,889 shares outstanding. The market capitalization of Serina Therapeutics is $84.14 million. Serina Therapeutics has a price to earnings ratio (PE ratio) of -6.00.

SER Latest News

More News

Form 8-K - Current report

July 18 2024
Edgar (US Regulatory)

Serina Therapeutics Appoints Srini Tenjarla, Ph.D. as Senior Vice President of CMC and Formulation

HUNTSVILLE, AL, July 18, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug...

July 18 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

July 17 2024
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

July 17 2024
Edgar (US Regulatory)

Form 8-K - Current report

July 12 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

July 10 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

May 23 2024
Edgar (US Regulatory)

Form 8-K - Current report

May 14 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.111.62790697679.46119.04166829.60635658CS
41.1111.7460317469.4511.3055.9262210548.57825726CS
122.0624.23529411768.514.575.9262206839.13990752CS
26-1.12-9.5890410958911.6819.935.9262156119.50818388CS
52-1.12-9.5890410958911.6819.935.9262156119.50818388CS
156-1.12-9.5890410958911.6819.935.9262156119.50818388CS
260-1.12-9.5890410958911.6819.935.9262156119.50818388CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WINTWindtree Therapeutics Inc
$ 8.24
(150.46%)
48.57M
BFIBurgerFi International Inc
$ 0.4206
(97.37%)
313.59M
NBSTWNewbury Street Acquisition Corporation
$ 0.1349
(92.71%)
122.1k
YIBOPlanet Image International Ltd
$ 2.915
(53.43%)
260.07k
CREVCarbon Revolution Public Ltd
$ 9.00
(45.87%)
8.06M
NMHINatures Miracle Holding Inc
$ 0.2035
(-48.06%)
7.69M
TANHTantech Holdings Ltd
$ 0.2585
(-47.23%)
6.75M
DXCMDexCom Inc
$ 64.00
(-40.66%)
53.92M
PSIGPS International Group Ltd
$ 1.42
(-31.40%)
716.26k
POAIPredictive Oncology Inc
$ 1.36
(-27.27%)
6.02M
SLNASelina Hospitality PLC
$ 0.0305
(-18.88%)
408.61M
BFIBurgerFi International Inc
$ 0.4206
(97.37%)
313.59M
NVDANVIDIA Corporation
$ 113.06
(0.69%)
293.33M
SQQQProShares UltraPro Short QQQ
$ 9.10
(-2.88%)
176.49M
SGMOSangamo Therapeutics Inc
$ 0.8612
(28.15%)
123.71M

Discussion

View Full Feed
Jimmy Joe Jimmy Joe 6 minutes ago
I mean is it hard to find a company that is profitable, or are we captives of $DBMM........

He knows exactly what is going on and only pretends when he makes lame arguments against $DBMM.

Funny thing is how he understands the litigation in NetList cases yet can't seem
DBMM
sharky sharky 7 minutes ago
9-1 buys vs sells on Friday. Accumulation picking up

$BLEG
BLEG
janice shell janice shell 8 minutes ago
LOLOLOLOL!!

Was writing a reply to your PM, but IHub PMs are down for maintenance. So I'll just post it here. Don't let the fascist moderators and admins know!!

Jesus. They're threatened by EVERYTHING. They want to be allowed to explore posters' "motivations". WTF? Ho
Murphydog25 Murphydog25 12 minutes ago
Your missing the point she's been back on X in the last 2 hours to answer no to RS but won't answer my and another persons questions about CIVET USA 🤷‍♂️ I can't find any information about it nor can you 🤷‍♂️
NWPN
noradio noradio 13 minutes ago
He has 600 posts on this board, you have 6000... Perhaps it is you who should be moving on.🤔
ERHE
jeunke22 jeunke22 14 minutes ago
Renewal of shelf offering to 100 Mio makes all business sense. Company has great cash ( until deep into 2025) position, has been very frugal in tapping funds from existing, running shelf from Roth and LPC. Both sources together could still provide around 40-45 mio under the ‘ old’ shelf and …
LWLG
spdpro spdpro 19 minutes ago
another good btc chart > and other stuff
https://www.centralcharts.com/en/charts/6863-btc-usd
https://www.centralcharts.com/en/charts/8595-nasdaq-composite
rockhunter rockhunter 20 minutes ago
Crazy to think that no one on here has even had no thoughts that if this oportunity is real... that there is actual millions... possibly billions... of dollars within our reach... that this could just be fun money for these new operators. Toying you all for a bit... stealing your shares.. running yo
HIRU
Welcome2Pinkyland Welcome2Pinkyland 21 minutes ago
For sure- superior grammar skills and the queen of the Ihub fraud team. The total package.
Truth and Transparency Truth and Transparency 21 minutes ago
Unfortunately, the amazing businessman that we believed Mr. Mark Smith to be is revealing himself to be the Mr. Bean of businessmen
NB
tmcfo tmcfo 22 minutes ago
You the man Adjusted! I hope they are nice enough to let you in as a major shareholder..buying more next week
MVNT
StocktonCA StocktonCA 23 minutes ago
very intrigueing, they added shares bc the purchaser knew the value will increase once significant trials have been completed. this company is way undervalued. big players in the know have loaded the boat bc they are aware of the exponential increase in bound.
GLTA longs who stayed on the bul
RSPI
BDEZ BDEZ 24 minutes ago
Thoughts? https://x.com/its_The_Dr/status/1816638114820972750
janice shell janice shell 25 minutes ago
❌️ is killing it....wouldn't it be sensible for us to give them a decent run for their money...we have the infrastructure and staff to do it

Srsly?? X is funded by one of the richest men in the world. IHub was created as a site to service penny plungers. It was initially quite succes
fuagf fuagf 26 minutes ago
Yep, knew that was your point.

2:34pm here. Enough. Cheers.
fuagf fuagf 28 minutes ago
Forever t'will be. Years ago something clicked for me, if an organization had a word like "freedom"
or "liberty" in it's name then watch out baby, it ain't good for but a relative wealthy few.

"There we go with the secretive opposite meaning group names. Again."
Nezitic Nezitic 28 minutes ago
Lol
PSRU
lakers17 lakers17 30 minutes ago
It’s a historic week for the cryptocurrency markets with spot ether exchange-traded funds making their debut.

Franklin Templeton is one of the nine spot ether ETF applicants which got approval Tuesday from the Securities and Exchange commission.

The firm is behind the F
The Night Stalker The Night Stalker 31 minutes ago
STAL big history of runs
STAL
Acme Investments Acme Investments 33 minutes ago
Well let's throw Tim Sykes into the conversation while we're at it!! Sell courses get rich, actually trade 99% fail!!
HIRU
BDEZ BDEZ 34 minutes ago
She can pretend she wasn’t the border czar (she was)

https://x.com/RealJamesWoods/status/1816872909224444195
BDEZ BDEZ 34 minutes ago
The ‘sloped roof’ in Butler, PA is flat

https://x.com/bennyjohnson/status/1816953010984984724
tradeherpete tradeherpete 35 minutes ago
I'll be checking the Anavex website around 8 or 9am on Sunday, maybe they'll have something interesting to say?
AVXL

Your Recent History

AMEX
SER
Serina Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved